ArticleMaterials (Basel, Switzerland)2021
Universal Model to Support the Quality Improvement of Industrial Products.
Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Predicting Design Solutions with Scenarios Considering the Quality of Materials and Products Based on a Life Cycle Assessment (LCA).Materials (Basel, Switzerland) · 2024Article
- A Novelty Procedure to Identify Critical Causes of Materials Incompatibility.Materials (Basel, Switzerland) · 2023Article
- Method of Fuzzy Analysis of Qualitative-Environmental Threat in Improving Products and Processes (Fuzzy QE-FMEA).Materials (Basel, Switzerland) · 2023Article
- Direct Recycling of WC-Co Grinding Chip.Materials (Basel, Switzerland) · 2023Article
- Method of Determining Sequence Actions of Products Improvement.Materials (Basel, Switzerland) · 2022Article
- A New Model Supporting Stability Quality of Materials and Industrial Products.Materials (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Improving the quality of industrial products quality still is a challenge. Despite using quality control, there is a constant need to support this process to achieve an effective, precise, and complex analysis of product quality. The purpose was to develop a universal model that supports improving the quality of products via the consistent and repetitive determination of the causes of product incompatibilities and actions leading to their elimination; the model can be integrated with any quality control of the product. The model verification was carried out for the incompatibility of the mechanical seal in alloy 410, in which the porosity cluster was identified by the fluorescence method (FPI). The purpose of the analysis was created by the SMART(-ER) method. Then, a team of experts was selected from which the brainstorming (BM) was realized. After the BM method, the source of incompatibility and initial causes were identified. Then, the Ishikawa diagram (according to rule 5M + E) was developed to group the initial causes. Next, during the BM method, the main causes were selected. In the last stage, the 5Why method was used to determine improvement actions, i.e., adjust clotting parameters, introduce the obligation to undergo periodic training, and set aside a separate place for storing the electrodes. Originality is the combination of selected quality management tools in a coherent model, the main aim of which is to identify the main causes of incompatibility and improvement actions. Additionally, this model is universal and has applications with analyzing any product and the causes of its incompatibility, and it can be integrated with any product quality control. Therefore, the model can be useful for improving the quality of products in any enterprise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.